{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:16:11Z","timestamp":1790882171870,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100014137","name":"Shanghai Shenkang Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2022CRD001"],"award-info":[{"award-number":["SHDC2022CRD001"]}],"id":[{"id":"10.13039\/501100014137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201246"],"award-info":[{"award-number":["82201246"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870667"],"award-info":[{"award-number":["81870667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171071"],"award-info":[{"award-number":["82171071"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013103","name":"Shanghai General Hospital","doi-asserted-by":"publisher","award":["CCTR-2022C02"],"award-info":[{"award-number":["CCTR-2022C02"]}],"id":[{"id":"10.13039\/501100013103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","award":["BCF-KH-YK-20230803-05"],"award-info":[{"award-number":["BCF-KH-YK-20230803-05"]}],"id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018625","name":"Science and Technology Innovation Plan Of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","award":["21XD1402700"],"award-info":[{"award-number":["21XD1402700"]}],"id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.numecd.2025.104271","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T23:23:13Z","timestamp":1754695393000},"page":"104271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of metabolic dysfunction-associated fatty liver disease with microvascular complications in adults with prediabetes"],"prefix":"10.1016","volume":"36","author":[{"given":"Jingtong","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0115-7160","authenticated-orcid":false,"given":"Kun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2025.104271_bib1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jama.2023.4063","article-title":"Diagnosis and management of prediabetes: a review","volume":"329","author":"Echouffo-Tcheugui","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2025.104271_bib3","article-title":"Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis","volume":"370","author":"Cai","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.numecd.2025.104271_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00125-021-05592-3","article-title":"Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies","volume":"65","author":"Schlesinger","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2025.104271_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","article-title":"The burden and risks of emerging complications of diabetes mellitus","volume":"18","author":"Tomic","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.numecd.2025.104271_bib6","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2025.104271_bib7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2025.104271_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2025.104271_bib9","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2025.104271_bib10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jhep.2024.01.014","article-title":"Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease","volume":"80","author":"Younossi","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2025.104271_bib11","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1111\/liv.16075","article-title":"Clinical outcomes of MAFLD versus NAFLD: a meta-analysis of observational studies","volume":"44","author":"Pennisi","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.numecd.2025.104271_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12072-023-10620-y","article-title":"Breaking new ground: MASLD vs. MAFLD\u2014Which holds the key for risk stratification?","volume":"18","author":"Ram\u00edrez-Mej\u00eda","year":"2024","journal-title":"Hepatol Int"},{"key":"10.1016\/j.numecd.2025.104271_bib13","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.jhep.2024.03.039","article-title":"Clinical features and long-term outcomes of patients diagnosed with MASLD, MAFLD, or both","volume":"81","author":"Zhou","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.numecd.2025.104271_bib14","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","article-title":"Non-alcoholic fatty liver disease and diabetes","volume":"65","author":"Hazlehurst","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.numecd.2025.104271_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3748\/wjg.v28.i3.310","article-title":"Non-alcoholic fatty liver disease and hepatocellular carcinoma: clinical challenges of an intriguing link","volume":"28","author":"Chrysavgis","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.numecd.2025.104271_bib16","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.eprac.2022.03.016","article-title":"Metabolic associated fatty liver disease increases the risk of systemic complications and mortality. A meta-analysis and systematic review of 12 620 736 individuals","volume":"28","author":"Quek","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.numecd.2025.104271_bib17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","article-title":"Current status and future trends of the global burden of MASLD","volume":"35","author":"Miao","year":"2024","journal-title":"Trends Endocrinol Metab TEM"},{"key":"10.1016\/j.numecd.2025.104271_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.pcd.2019.03.009","article-title":"Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes","volume":"13","author":"Afarideh","year":"2019","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.numecd.2025.104271_bib19","article-title":"Presence of diabetic retinopathy is lower in type 2 diabetic patients with non-alcoholic fatty liver disease","volume":"98","author":"Zhang","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.numecd.2025.104271_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1147458","article-title":"Non-alcoholic fatty liver disease and incidence of microvascular complications of diabetes in patients with type 2 diabetes: a prospective cohort study","volume":"14","author":"Deravi","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.numecd.2025.104271_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/joim.13673","article-title":"Increased risk for microvascular outcomes in NAFLD-A nationwide, population-based cohort study","volume":"294","author":"Ebert","year":"2023","journal-title":"J Intern Med"},{"key":"10.1016\/j.numecd.2025.104271_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154874","article-title":"Non-alcoholic fatty liver disease, metabolic goal achievement with incident cardiovascular disease and eGFR-based chronic kidney disease in patients with prediabetes and diabetes","volume":"124","author":"Li","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.numecd.2025.104271_bib23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12933-024-02516-4","article-title":"Combined impact of prediabetes and hepatic steatosis on cardiometabolic outcomes in young adults","volume":"23","author":"Choi","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2025.104271_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.numecd.2025.104271_bib25","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2025.104271_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.numecd.2025.104271_bib27","first-page":"1201","article-title":"External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study","volume":"11","author":"Koehler","year":"2013","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.numecd.2025.104271_bib28","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/EJE-14-0112","article-title":"External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals","volume":"171","author":"Cuthbertson","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.numecd.2025.104271_bib29","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/jgh.15799","article-title":"Validation of five hepatic steatosis algorithms in metabolic-associated fatty liver disease: a population based study","volume":"37","author":"Liu","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2025.104271_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13098-022-00811-2","article-title":"Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease","volume":"14","author":"Han","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.numecd.2025.104271_bib31","article-title":"Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease","volume":"5","author":"Ho","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.numecd.2025.104271_bib32","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.numecd.2025.104271_bib33","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2025.104271_bib34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/apt.14219","article-title":"Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD","volume":"46","author":"Petta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.numecd.2025.104271_bib35","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/jama.2019.9879","article-title":"Association of Lifestyle and genetic risk with incidence of dementia","volume":"322","author":"Lourida","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.numecd.2025.104271_bib36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.4103\/0973-3930.70861","article-title":"Association of non-alcoholic fatty liver disease with diabetic microvascular and macrovascular complications in south Indian diabetic subjects","volume":"30","author":"Viswanathan","year":"2010","journal-title":"Int J Diabetes Dev Ctries"},{"key":"10.1016\/j.numecd.2025.104271_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101497","article-title":"MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus","volume":"50","author":"Mantovani","year":"2024","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.numecd.2025.104271_bib38","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/jdi.13489","article-title":"Association of non-alcoholic fatty liver disease with diabetic retinopathy in type 2 diabetic patients: a meta-analysis of observational studies","volume":"12","author":"Song","year":"2021","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.numecd.2025.104271_bib39","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.eprac.2021.02.004","article-title":"Association between non-alcoholic fatty liver disease and diabetes-related microvascular complications: a retrospective cross-sectional study of hospitalized patients","volume":"28","author":"Wen","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/j.numecd.2025.104271_bib40","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/liv.14274","article-title":"Liver fibrosis by FibroScan\u00ae independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes","volume":"40","author":"Lombardi","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.numecd.2025.104271_bib41","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/MEG.0000000000002767","article-title":"Metabolic dysfunction-associated steatotic liver disease-related hepatic fibrosis increases risk of insulin resistance, type 2 diabetes, and chronic kidney disease","volume":"36","author":"Zhang","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2025.104271_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108884","article-title":"Significant liver fibrosis, as assessed by fibroscan, is independently associated with chronic vascular complications of type 2 diabetes: a multicenter study","volume":"177","author":"Mikolasevic","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.numecd.2025.104271_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101478","article-title":"Retinopathy as a predictive indicator for significant hepatic fibrosis according to T2DM status: a cross-sectional study based on the national health and nutrition examination survey data","volume":"29","author":"Li","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.numecd.2025.104271_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-03870-z","article-title":"Liver fibrosis indices are related to diabetic peripheral neuropathy in individuals with type 2 diabetes","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2025.104271_bib45","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.numecd.2025.104271_bib46","article-title":"Non-alcoholic fatty liver disease in women \u2013 current knowledge and emerging concepts","volume":"5","author":"Eng","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.numecd.2025.104271_bib47","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus \u2014 mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325004259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325004259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:26:54Z","timestamp":1778776014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475325004259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0939475325004259"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104271","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of metabolic dysfunction-associated fatty liver disease with microvascular complications in adults with prediabetes","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104271","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104271"}}